Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Birnbaum

Showing results (221-230 of 301) with videos related to

Pageof 31
Sort By:
Genes & Development|April 14, 2017
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapyRuth Rodriguez-Barrueco, Erin A Nekritz, François Bertucci, et al.
Current Topics in Medicinal Chemistry|September 18, 2012
Search for distinctive markers in DNT and cortical grade II glioma in children: same clinicopathological and molecular entities?Laetitia Padovani, Carole Colin, Carla Fernandez, et al.
Genes, Chromosomes & Cancer|April 11, 2012
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasmsMandy Brecqueville, Jérôme Rey, François Bertucci, et al.
Cell Stem Cell|March 29, 2008
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeChristophe Ginestier, Min Hee Hur, Emmanuelle Charafe-Jauffret, et al.
Neoplasia (New York, N.Y.)|June 14, 2017
Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)Madhura Joglekar-Javadekar, Steven Van Laere, Michael Bourne, et al.
Genes, Chromosomes & Cancer|September 28, 2002
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT geneCornel Popovici, Céline Basset, François Bertucci, et al.
Breast (Edinburgh, Scotland)|March 16, 2007
Inflammatory breast cancers in Tunisia and France show similar immunophenotypesEmmanuelle Charafe-Jauffret, Karima Mrad, Sana Intidhar Labidi, et al.
Oncotarget|April 11, 2015
Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changesRaynier Devillier, Véronique Mansat-De Mas, Veronique Gelsi-Boyer, et al.
International Journal of Cancer|June 28, 2007
Moesin expression is a marker of basal breast carcinomasEmmanuelle Charafe-Jauffret, Florence Monville, François Bertucci, et al.
British Journal of Haematology|April 25, 2009
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemiaVéronique Gelsi-Boyer, Virginie Trouplin, José Adélaïde, et al.
Pageof 31

Showing results (221-230 of 301) with videos related to

Sort By:
Pageof 31
Genes & Development|April 14, 2017
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapyRuth Rodriguez-Barrueco, Erin A Nekritz, François Bertucci, et al.
Current Topics in Medicinal Chemistry|September 18, 2012
Search for distinctive markers in DNT and cortical grade II glioma in children: same clinicopathological and molecular entities?Laetitia Padovani, Carole Colin, Carla Fernandez, et al.
Genes, Chromosomes & Cancer|April 11, 2012
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasmsMandy Brecqueville, Jérôme Rey, François Bertucci, et al.
Cell Stem Cell|March 29, 2008
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeChristophe Ginestier, Min Hee Hur, Emmanuelle Charafe-Jauffret, et al.
Neoplasia (New York, N.Y.)|June 14, 2017
Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)Madhura Joglekar-Javadekar, Steven Van Laere, Michael Bourne, et al.
Genes, Chromosomes & Cancer|September 28, 2002
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT geneCornel Popovici, Céline Basset, François Bertucci, et al.
Breast (Edinburgh, Scotland)|March 16, 2007
Inflammatory breast cancers in Tunisia and France show similar immunophenotypesEmmanuelle Charafe-Jauffret, Karima Mrad, Sana Intidhar Labidi, et al.
Oncotarget|April 11, 2015
Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changesRaynier Devillier, Véronique Mansat-De Mas, Veronique Gelsi-Boyer, et al.
International Journal of Cancer|June 28, 2007
Moesin expression is a marker of basal breast carcinomasEmmanuelle Charafe-Jauffret, Florence Monville, François Bertucci, et al.
British Journal of Haematology|April 25, 2009
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemiaVéronique Gelsi-Boyer, Virginie Trouplin, José Adélaïde, et al.
Pageof 31